发明名称 |
Benzoimidazol-2-yl pyrimidine modulators of the histamine H<sub>4 </sub>receptor |
摘要 |
Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus. |
申请公布号 |
US9434715(B2) |
申请公布日期 |
2016.09.06 |
申请号 |
US201615047359 |
申请日期 |
2016.02.18 |
申请人 |
Janssen Pharmaceutica NV |
发明人 |
Conza Matteo;Hickey Magali B.;Horns Stefan;Lochner Susanne |
分类号 |
A61K31/506;C07D401/14;C07C51/43;C30B7/08;C30B29/54 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of obtaining a purified pharmaceutically acceptable salt of a [5-(4,6-dimethyl-1H-benzoimidazol-2-yl)-4-methyl-pyrimidin-2-yl]-[3-(1-methyl-piperidin-4-yl)-propyl]-amine, comprising:
forming a hemitartrate salt of the compound of formula (2):in water to yield an aqueous hemitartrate salt solution;
seeding said aqueous solution with crystal seeds of the tetrahydrate of said hemitartrate to obtain a seeded aqueous solution; and crystallizing out of said seeded aqueous solution the solid tetrahydrate hemitartrate of formula (3): |
地址 |
Beerse BE |